ConductScience.org, home

Trial · NCT00785577

Results by group169

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Change From Baseline in Weekly Mean 24-hour Average Pain Severity (APS) Score at 5 WeeksPlacebo-2.08Standard Error 0.22units on a scale
Change From Baseline in Weekly Mean 24-hour Average Pain Severity (APS) Score at 5 WeeksLY545694 21 mg-2.22Standard Error 0.36units on a scale
Change From Baseline in Weekly Mean 24-hour Average Pain Severity (APS) Score at 5 WeeksLY545694 49 mg-2.45Standard Error 0.32units on a scale
Change From Baseline in Weekly Mean 24-hour Average Pain Severity (APS) Score at 5 WeeksLY545694 105 mg-2.42Standard Error 0.33units on a scale
Change From Baseline in Weekly Mean Night Pain Severity Score at 5 WeeksPlacebo-2.31Standard Error 0.23units on a scale
Change From Baseline in Weekly Mean Night Pain Severity Score at 5 WeeksPregabalin-2.75Standard Error 0.33units on a scale
Change From Baseline in Weekly Mean Night Pain Severity Score at 5 WeeksLY545694 21 mg-2.25Standard Error 0.37units on a scale
Change From Baseline in Weekly Mean Night Pain Severity Score at 5 WeeksLY545694 49 mg-2.54Standard Error 0.33units on a scale
Change From Baseline in Weekly Mean Night Pain Severity Score at 5 WeeksLY545694 105 mg-2.21Standard Error 0.34units on a scale
Change From Baseline in Weekly Mean Worst Daily Pain Severity Score at 5 WeeksPlacebo-2.27Standard Error 0.25units on a scale
Change From Baseline in Weekly Mean Worst Daily Pain Severity Score at 5 WeeksPregabalin-2.87Standard Error 0.35units on a scale
Change From Baseline in Weekly Mean Worst Daily Pain Severity Score at 5 WeeksLY545694 21 mg-2.57Standard Error 0.40units on a scale
Change From Baseline in Weekly Mean Worst Daily Pain Severity Score at 5 WeeksLY545694 49 mg-2.77Standard Error 0.35units on a scale
Change From Baseline in Weekly Mean Worst Daily Pain Severity Score at 5 WeeksLY545694 105 mg-2.67Standard Error 0.37units on a scale
Number of Participants With 30% Reduction in Weekly Mean 24-hour Average Pain Severity (APS) ScorePlacebo38participants
Number of Participants With 30% Reduction in Weekly Mean 24-hour Average Pain Severity (APS) ScoreLY545694 21 mg18participants
Number of Participants With 30% Reduction in Weekly Mean 24-hour Average Pain Severity (APS) ScoreLY545694 49 mg21participants
Number of Participants With 30% Reduction in Weekly Mean 24-hour Average Pain Severity (APS) ScoreLY545694 105 mg21participants
Change From Baseline in Average Brief Pain Inventory - Interference (BPI-I) Subscale Score at 5 WeeksPlacebo-2.73Standard Error 0.25units on a scale
Change From Baseline in Average Brief Pain Inventory - Interference (BPI-I) Subscale Score at 5 WeeksPregabalin-2.81Standard Error 0.34units on a scale

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00785577/results